Clicky

Toshiba Corp.(6502)

Description: OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.


Keywords: Medicine Artificial Intelligence Disease Antibiotics Infection Medical Test Molecular Diagnostics Antimicrobial Bioinformatics Veterinary Medicine Healthcare Institutions Antimicrobial Resistance Evolutionary Biology Multiple Drug Resistance

Home Page: www.opgen.com

9717 Key West Avenue
Rockville, MD 20850
United States
Phone: 240 813 1260


Officers

Name Title
Dr. Oliver Schacht Ph.D. CEO, Pres & Director
Mr. Johannes Bacher Chief Operating Officer
Mr. Albert Weber CFO & Corp. Sec.
Mr. Vadim Sapiro Chief Information Officer
Mr. Michael Farmer VP of Marketing
Ms. Faranak Atrzadeh Chief Marketing & Scientific Affairs Officer
Dr. G. Terrance Walker Ph.D. Sr. VP of R&D
Mr. Derek Joesting Sr. VP of US Sales
Dr. Arne Materna MD & CEO of Ares Genetics GmbH

Exchange: F

Country: DE

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.601
Price-to-Sales TTM: 2.0855
IPO Date:
Fiscal Year End: December
Full Time Employees: 91
Back to stocks